JNJ-2113
- Generic Name
- JNJ-2113
A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 227
- Registration Number
- NCT05364554
- Locations
- πΊπΈ
Pacific Skin Institute, Sacramento, California, United States
πΊπΈRenstar Medical Research, Ocala, Florida, United States
πΊπΈForcare Clinical Research Inc, Tampa, Florida, United States
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
- First Posted Date
- 2022-05-03
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 90
- Registration Number
- NCT05357755
- Locations
- π¨π¦
Dermatology Research Institute Inc, Calgary, Alberta, Canada
πΊπΈStoll Dermatology, Beverly Hills, California, United States
πΊπΈNorthshore University Healthsystem, Skokie, Illinois, United States
A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 255
- Registration Number
- NCT05223868
- Locations
- π©πͺ
ISA - Interdisciplinary Study Association GmbH, Berlin, Germany
π©πͺNiesmann & Othlinghaus GbR, Bochum, Germany
π©πͺRosenpark Research GmbH, Darmstadt, Germany
A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 36
- Registration Number
- NCT05062200
- Locations
- π―π΅
Souseikai Hakata Clinic, Fukuoka, Japan
Pharmacokinetics of PN-235 in Healthy Volunteers
- First Posted Date
- 2020-11-09
- Last Posted Date
- 2022-02-18
- Lead Sponsor
- Protagonist Therapeutics, Inc.
- Target Recruit Count
- 107
- Registration Number
- NCT04621630
- Locations
- π¦πΊ
Nucleus Network Melbourne Clinic, Melbourne, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath